Ciliopathies: Clinical Trials

374 trials for Ciliopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

175 completed, 78 recruiting, 40 unknown, 27 active not recruiting. 71 Phase 2, 66 Not applicable, 47 Phase 3, 36 Phase 1, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 271Completed 39, Terminated 10, Recruiting 9, Unknown 6, Active not recruiting 5, Enrolling by invitation 1, Withdrawn 1
Not applicable66Completed 28, Recruiting 14, Unknown 8, Not yet recruiting 5, Active not recruiting 4, Terminated 4, Enrolling by invitation 2, Withdrawn 1
Phase 347Completed 24, Terminated 10, Unknown 6, Recruiting 5, Active not recruiting 1, Withdrawn 1
Phase 136Completed 21, Not yet recruiting 6, Recruiting 5, Terminated 2, Active not recruiting 1, Unknown 1
Phase 49Completed 4, Active not recruiting 2, Unknown 2, Recruiting 1
Early Phase 14Completed 2, Terminated 2

Follow Ciliopathies: new trials by email Literature Review of Ciliopathies trials Research Report on Ciliopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose
14C-VX-407 - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1Not yet recruitingVertex Pharmaceuticals Incorporated82026-10-192026-10-09
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
VX-407, LNG/EE, NGM/EE - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 1RecruitingVertex Pharmaceuticals Incorporated1482026-09-012026-09-30
Bempedoic Acid Therapy for Polycystic Kidney Disease
Bempedoic Acid 180 MG Oral Tablet, Placebo Capsule(s) - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 2RecruitingKenneth Hallows1202026-09-012026-09-29
Malnutrition and Sarcopenia Among Primary Ciliary Dyskinesia
Physical assessments of individuals - Primary Ciliary Dyskinesia (PCD)
Not yet recruitingIzmir Democracy University152026-08-032026-07-31
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy Controls
Physical Evaluations in Children with Primary Ciliary Dyskinesia, Physical Evaluations in Healthy Children - Primary Ciliary Dyskinesia (PCD)
Not yet recruitingIzmir Democracy University302026-08-012026-07-31
Clearance in Primary Ciliary Dyskinesia
Exercise, HS pretreatment with Exercise - Primary Ciliary Dyskinesia, PCD
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill82026-07-302026-07-13
Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System Hemangioblastomas
Von Hippel-Lindau Disease, Central Nervous System Hemangioblastoma
Not yet recruitingAssistance Publique - Hôpitaux de Paris252026-07-152026-07-15
Dietary Modulation of Urinary MCP-1 in ADPKD
Carbohydrate Restricted, Plant Dominant Diet, usual diet - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Not applicableNot yet recruitingAssaf-Harofeh Medical Center362026-07-102026-06-26
A Phase 1 Study of Single and Multiple Ascending Doses of GV-100
GV-100, Placebo - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 1RecruitingGilva Therapeutics Inc.802026-06-232026-08-26
Managing Depressive Symptoms in ADPKD
Mayo Clinic-Approved Education, Digital Neuropathy, Capacity Coaching - Autosomal Dominant Polycystic Kidney Disease
Not applicableRecruitingMayo Clinic1052026-06-122026-08-07
Drug-Drug Interactions of JMKX003142 in Healthy Participants
JMKX003142 tablets, Fluconazole Capsules, Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets) - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 1Not yet recruitingJemincare1122026-05-112026-05-04
Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease
Interventional Diet - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Not applicableNot yet recruitingLoma Linda University302026-05-012026-01-30
Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome.
VHL - Von Hippel-Lindau Syndrome
Active not recruitingIRCCS Ospedale San Raffaele2002026-05-012026-05-11
Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases
Videoconferencing (Vsee platform), Specially designed website (FysΑΩ) - Chronic Suppurative Lung Disease, Protracted Bacterial Bronchitis
Not applicableNot yet recruitingUniversity of Thessaly322026-05-012026-01-30
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
18F-T2 PET/CT - Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC)
Not applicableRecruitingPeking University First Hospital2002026-04-272026-05-14
Developing Resource Interventions for Healthcare Professionals and Patients to Improve Knowledge About Fertility in Primary Ciliary Dyskinesia
Online educational resource, Toolkit for healthcare professionals - Primary Ciliary Dyskinesia (PCD), Fertility
Not applicableNot yet recruitingUniversity of Southampton302026-04-012026-04-15
A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults
JMKX003142 tablets, Placebo - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 1Not yet recruitingJemincare242026-03-272026-03-13
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Belzutifan, Nivolumab, Lenvatinib - Von Hippel-Lindau Disease, Malignant Neoplasms
Phase 3RecruitingMerck Sharp & Dohme LLC4502026-03-232026-10-21
Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers
[14C]JMKX003142, JMKX003142 tablets, [14C]JMKX003142 solution for infusion - ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Phase 1Not yet recruitingJemincare82026-03-182026-03-10
Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Ren-Nu and KetoCitra - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Not applicableRecruitingRichard Fatica202026-02-252026-03-06

Showing 20 of 374. Sign in to see all of them.

Narrower conditions

Polycystic Kidney, Autosomal Dominant (182)  ·  Ciliary Motility Disorders (79)  ·  Polycystic Kidney Diseases (58)  ·  von Hippel-Lindau Disease (55)  ·  Kartagener Syndrome (21)  ·  Cystic Fibrosis (20)  ·  Bardet-Biedl Syndrome (18)  ·  Kidney Diseases (15)  ·  Renal Insufficiency, Chronic (15)  ·  Carcinoma, Renal Cell (14)  ·  Polycystic liver disease (13)  ·  Hypertension (11)  ·  Hemangioblastoma (10)  ·  Obesity (9)  ·  Polycystic Kidney, Autosomal Recessive (8)

Broader conditions

Abnormalities, Multiple (374)  ·  Congenital Abnormalities (374)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (374)  ·  Genetic Diseases, Inborn (370)  ·  Female Urogenital Diseases and Pregnancy Complications (241)  ·  Urogenital Diseases (241)  ·  Female Urogenital Diseases (240)  ·  Male Urogenital Diseases (239)  ·  Urologic Diseases (237)  ·  Kidney Diseases (222)  ·  Kidney Diseases, Cystic (214)  ·  Polycystic Kidney Diseases (159)  ·  Cardiovascular Diseases (94)  ·  Nervous System Diseases (88)

Interventions

Tolvaptan (21)  ·  Blood Specimen Collection (9)  ·  Sirolimus (9)  ·  belzutifan (5)  ·  lixivaptan (5)  ·  setmelanotide (5)  ·  Everolimus (4)  ·  Metformin (4)  ·  Sodium Chloride (4)  ·  XL647 (4)  ·  lanreotide (4)  ·  Diet (3)  ·  Diet, Ketogenic (3)  ·  Pravastatin (3)  ·  Ranibizumab (3)

Sponsors

Mayo Clinic (15)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (12)  ·  University of Colorado, Denver (12)  ·  Mario Negri Institute for Pharmacological Research (11)  ·  University of North Carolina, Chapel Hill (11)  ·  Assistance Publique - Hôpitaux de Paris (9)  ·  National Eye Institute (NEI) (7)  ·  Vertex Pharmaceuticals Incorporated (7)  ·  Jemincare (6)  ·  Gazi University (5)  ·  M.D. Anderson Cancer Center (5)  ·  National Cancer Institute (NCI) (5)  ·  Palladio Biosciences (5)  ·  ReCode Therapeutics (5)  ·  The Rogosin Institute (5)

Countries

United States (170)  ·  France (45)  ·  Italy (39)  ·  United Kingdom (38)  ·  Germany (34)  ·  Canada (31)  ·  Netherlands (30)  ·  Spain (25)  ·  Belgium (23)  ·  Australia (21)  ·  Turkey (Türkiye) (20)  ·  Denmark (19)  ·  Japan (18)  ·  China (16)  ·  Switzerland (13)

Top investigators

Jon Blumenfeld, MD (4)  ·  David Meeker, MD (3)  ·  Eric Jonasch, MD (3)  ·  John Matthews, MBBS, MCRP, PhD (3)  ·  Marva Moxey-Mims, M.D. (3)  ·  Naris Nilubol, M.D. (3)  ·  Vicente Torres, MD, PhD (3)  ·  Arlene Chapman, M.D. (2)  ·  Arlene Chapman, MD (2)  ·  Changlin Mei, MD (2)  ·  Claudia E Kuehni, Prof (2)

Results publications

PMID 39356039, PMID 41385299, PMID 37250503, PMID 41348481, PMID 36191725, PMID 37349694, PMID 38837240, PMID 31014270, PMID 34783716, PMID 21903984, PMID 23477994, PMID 37729939, PMID 37986188, PMID 38072392, PMID 40377984, PMID 11562511, PMID 16221708, PMID 16627867, PMID 16858015, PMID 17059358, PMID 17449765, PMID 17515466, PMID 17804777, PMID 17868472, PMID 18026621, PMID 18372389, PMID 19141364, PMID 19525519, PMID 19540516, PMID 20350728, PMID 20581391, PMID 20581392, PMID 20876670, PMID 21270641, PMID 21354816, PMID 21514598, PMID 21694639, PMID 21757630, PMID 21926392, PMID 21926394, PMID 21926395, PMID 21926396, PMID 22105611, PMID 22113127, PMID 22177992, PMID 22184204, PMID 22205355, PMID 22276227, PMID 22328589, PMID 22417271

NIH funding

U54HL096458 (5), 2017 (3), 2018 (3), 2023 (3), 2025 (2), U01DK062401 (2), U01DK082230 (2), 2005 (1), 2014 (1), 2015 (1), 2016 (1), 2019 (1), P30DK048520 (1), P30DK074038 (1), P30DK090868 (1)